Perceptive's fourth — yes, fourth — SPAC jumps to Nasdaq as the blank check tree continues to ripen
The biotech SPAC boom has gone almost hand-in-hand with the industry’s IPO gold rush, and this week saw more blank check companies hop aboard …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
